Excited for the pub on our translational analyses suggesting different types of genomic alterations associated with response in NSCLC #jitc @BHenickMD @CatherineShuMD
New #JITC article: Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings bit.ly/49TdeqN @BHenickMD @DrMarkAwad @BizarMd @JustinGainor @CatherineShuMDView quoted post on X